Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read MoreVitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa
Wednesday, February 21 2024 | 07 h 53 min | Vision Science & Research
A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...
Read MoreDiversity and Inclusion in Eye Care
Thursday, November 30 2023 | 08 h 51 min | Optik Magazine
By Dr Trevor Miranda, OD Canada is an intricate textured tapestry of different cultures Each patient is unique and presents with different...
Read MoreStudents and Binocular Vision: The Hidden Obstacle
Tuesday, November 28 2023 | 14 h 36 min | Clinical Practice, Optik Magazine
By Dr Jenny Lee, OD Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting...
Read MoreOptometry to Optometry: An Untapped Resource for Better Health Care Delivery
Wednesday, November 22 2023 | 13 h 47 min | Clinical Practice, Optik Magazine
By Dr Sophia Leung, OD, FAAO, FCCSO, Dipl ABO, Dipl Ant Seg Intraprofessional collaboration is not new to health care Although only making up a...
Read More